DUBLIN, Aug 23, 2018 /PRNewswire/ --
The "North America Oligosaccarides in Infant Nutrition Market - Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.
North America oligosaccharides in infant nutrition market is expected to register a healthy CAGR in the forecast period 2018 to 2025
The new market report contains data for historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025. Prominent factors driving the growth of this market consist of growing numbers of working mothers, rising birth rate, inability of mothers to lactate sufficiently and health benefits offered by oligosaccharide are driving the oligosaccharide in infant nutrition market.
The North America oligosaccharides in infant nutrition market are segmented based on type into galactoligosaccharides, human milk oligosaccharides, fructooligosaccharides and others. In 2018, galactoligosaccharides segment is estimated to rule with 46.6% shares and will cross USD 27.70 million by 2025, rising at the highest CAGR of 8.6%. Human milk oligosaccharides are sub segmented into Fucosyllactose, LNT & LNnT and sialyllactose.
The North America oligosaccharides in infant nutrition market are segmented based on source into bacteria, plants, algae, fungi and others. In 2018, bacteria segment is estimated to rule with the highest market share.
The North America oligosaccharides in infant nutrition market are segmented based on form into powder and liquid. In 2018, powder segment is estimated to rule with the highest market share.
The key market players for North America oligosaccharides in infant nutrition market are listed below:
- DuPont Nutrition & Health
- FrieslandCampina Domo
- Abbott
- Ingredion
- Carbosynth
- Dairy Crest
- Dextra Laboratories Limited
- Elicityl SA
- Inbiose NV
- Jennewein Biotechnologie GmbH
- Tereos
- ZuChem
Key Topics Covered:
1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Overview of North America Oligosaccharides In Infant Nutrition Market
1.4 Currency and Pricing
1.5 Limitation
1.6 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographic Scope
2.3 Years Considered For the Study
2.4 Currency and Pricing
2.5 Research Methodology
2.6 Primary Interviews With Key Opinion Leaders
2.7 Market Position Grid
2.8 Secondary Sources
2.9 Assumptions
3 Market Overview
3.1 Drivers
3.1.1 Growing Number of Working Mothers
3.1.2 Rising Birth Rate
3.1.3 Inability of Mothers To Lactate Sufficiently
3.1.4 Health Benefits Offered by Infant Formula Or Oligosacharide
3.2 Restraints
3.2.1 Threat of Allergies Or Autoimmune Diseases
3.2.2 Stringent Regulations
3.2.3 Increasing Awareness For Natural Infant Feeding
3.3 Opportunity
3.3.1 Increasing Demand of Organic Products
3.4 Challenge
3.4.1 High Cost of Products
4 Executive Summary
5 Premium Insights
6 North America Oligosachride In Infant Nutrition Market, by Type
6.1 Overview
6.2 Galactooligosaccharides
6.3 Human Milk Oligosaccharides
6.3.1 Fucosyllactose
6.3.2 LNT & LNNT
6.3.3 Sialyllactose
6.4 Fructoligosaccharides
6.5 Others
7 North America Oligosachride In Infant Nutrition Market, by Source
7.1 Overview
7.2 Bacteria
7.3 Plants
7.4 Algae
7.5 Fungi
7.6 Others
8 North America Oligosachride In Infant Nutrition Market, by Form
8.1 Overview
8.2 Powder
8.3 Liquid
9 North America Oligosaccharides In Infant Nutrition Market, by Geography
9.1 North America
9.1.1 U.S.
9.1.2 Canada
9.1.3 Mexico
10 North America Oligosaccharides In Infant Nutrition Market, Company Landscape
10.1 Company Share Analysis: North America
11 Company Profiles
For more information about this report visit https://www.researchandmarkets.com/research/3gjcwd/north_america?w=5
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article